Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer

Oncologist

Volumn 7, Issue 5, 2002, Pages 418-423

  Van Praagh, Isabelle ^a   Cure, Hervé ^a   Leduc, Bernard ^b   Charrier, Sabine ^a   Le Bouedec, Guillaume ^a   Achard, Jean Louis ^a   Ferriere, Jean Pierre ^a   Feillel, Viviane ^a   De Latour, Monique ^a   Dauplat, Jacques ^a   Chollet, Philippe ^a  

^a CENTRE JEAN PERRIN   (France)

^b Centre Hospitalier General   (France)

Author keywords

Breast cancer; Epirubicin; Methotrexate; Neoadjuvant therapy; Vinorelbine

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; NAVELBINE; PIRARUBICIN; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURGERY; DIARRHEA; DRUG EFFICACY; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NAUSEA; NEUROLOGIC DISEASE; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; MASTECTOMY; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPENIA; TREATMENT OUTCOME; VINBLASTINE;

EID: 18644371828     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.7-5-418     Document Type: Article

References (15)

1. Hortobagyi GN, Buzdar AU. Locally advanced breast cancer. A review including the M.D. Anderson experience. In: Raga H, Anel IM, eds. High Risk Cancer. Berlin: Springer Verlag, 1991:382-415.
2. Esteva FJ, Hortobagyi GN. Integration of systemic chemotherapy in the management of primary breast cancer. The Oncologist 1998;3:300-313.
3. Fisher B, Bryant J, Wolmark N et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-2685.
4. Fumoleau P, Delgado FM, Delozier T et al. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 1993;11:1245-1252.
5. Spielmann M, Dorval T, Turpin F et al. Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 1994;12:1764-1770.
6. Nistico C, De Matteis A, Valenze R et al. Epirubicin and vinorelbine: A new promising combination for primary systemic chemotherapy for operable breast cancer patient. Proc Am Soc Clin Oncol 1998;17:A622.
7. Mamounas EP. NASBP protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. Oncology (Huntingt) 1997;11:37-40.
8. Belembaogo E, Feillel V, Chollet P et al. Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer 1992;28A:896-900.
9. Miller AB, Hoogstraten B, Staquet M. Reporting results of cancer treatment. Cancer 1981;47:207-214.
10. Chevallier B, Roche H, Olivier JP et al. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 1993;16:223-228.
11. Bines J, Oleska DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-1729.
12. Pouillart P, Fumoleau P, Romieu G et al. Final results of a phase II randomized parallel study of doxorubicin/cyclophosphamide (AC) and doxorubicin/Taxol® (paclitaxel) (AT) as neoadjuvant treatment of loco-regional breast cancer. Proc Am Soc Clin Oncol 1999;18:73a.
13. Jacquillat C, Weil M, Baillet F et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990;66:119-129.
14. Chollet P, Charrier S, Brain E et al. Clinical and pathological response to primary chemotherapy in operable breast cancer. Eur J Cancer 1997;6:862-866.
15. Van Praagh I, Martineau N, Curé H et al. Efficacy of a chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) in locally advanced and metastatic breast cancer. Proc Am Soc Clin Oncol 1993;12:180a.